Content about Branded

August 2, 2011
FDA gives new approval to Novartis MS drug

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

August 2, 2011
FDA gives tentative approval to Intelliject device

The Food and Drug Administration has given tentative approval to an emergency treatment for severe allergic reactions made by Intelliject, the drug maker said.

August 2, 2011
Merrimack gets orphan drug designation for pancreatic cancer treatment

The Food and Drug Administration has granted orphan drug designation to a chemotherapy drug made by Merrimack Pharmaceuticals for pancreatic cancer, the drug maker said Monday.

August 1, 2011
FDA approves subcutaneous formulation of Orencia

The Food and Drug Administration has approved a drug made by Bristol-Myers Squibb for injection under the skin to treat rheumatoid arthritis, Bristol said Friday.

August 1, 2011
Federal court upholds Lilly patent

A federal court has upheld Eli Lilly's patent covering a drug used to treat attention deficit hyperactivity disorder, Lilly said Friday.

August 1, 2011
Lilly, Lupin enter diabetes partnership

Eli Lilly’s India division and Indian generic drug maker Lupin will distribute Lilly’s insulin products in India and Nepal under an agreement between the two companies announced Friday.

July 29, 2011
FDA to Eisai: Redo application for perampanel

The Food and Drug Administration has asked Eisai to redo its regulatory application for a drug to treat epilepsy, Eisai said Friday.

July 29, 2011
Merck announces plans to trim workforce

Merck disclosed plans to reduce its workforce by 12% to 13% by the end of 2015, the company announced Friday in its second-quarter earnings release.

July 29, 2011
Teva launches authorized generic of Seasonique

Teva Pharmaceuticals has launched an authorized generic version of a contraceptive made by Duramed Pharmaceuticals, Teva said.

July 28, 2011
Biogen Idec expands MS ActiveSource

Biogen Idec has expanded its online resource for patients living with multiple sclerosis to include new resources and support programs.

July 28, 2011
Bydureon reply submitted to FDA

Drug makers Eli Lilly, Amylin Pharmaceuticals and Alkermes are giving their long-acting form of an injected drug for Type 2 diabetes another try at the Food and Drug Administration.

July 28, 2011
GSK expects to divest noncore OTC brands by late 2011, company says

GlaxoSmithKline expects to close the deal on the divestiture of several over-the-counter brands that were identified in April, the company stated Tuesday as part of its second-quarter earnings results.

July 28, 2011
Pfizer to acquire Icagen

Pfizer has entered a definitive agreement to acquire a biopharmaceutical company that focuses on the development of pain treatments.

July 28, 2011
Sanofi announces executive changes

The president and CEO of Sanofi's U.S. operations is stepping into a newly created role at the drug maker.

July 27, 2011
Lilly aims to educate consumers on how drug maker collaborates with physicians

Eli Lilly has launched its physician payment registry, a website that enables visitors to search payments to individual U.S.-based physicians and the institutions or research organizations that receive payments on behalf of a physician.

July 26, 2011
Impax enrolls patients into late-stage trial for Parkinson's treatment

The branded drugs division of Impax Labs has finished enrolling patients in a late-stage trial of a drug for Parkinson’s disease.

July 26, 2011
Takeda resubmits new drug applications for Type 2 diabetes treatments

Japanese drug maker Takeda Pharmaceutical is reapplying for approval of two drugs to treat Type 2 diabetes after the Food and Drug Administration turned down its last applications, the company said.

July 25, 2011
Welchol oral suspension now can be mixed with fruit juice, diet soft drinks or water

The Food and Drug Administration has approved a new means of administration for a drug made by Daiichi Sankyo, the drug maker said Monday.

July 22, 2011
Bristol to acquire Amira

Bristol-Myers Squibb will acquire San Diego-based Amira Pharmaceuticals for $325 million, the two companies said Friday.

July 21, 2011
Brilinta receives FDA approval

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

July 21, 2011
FDA OKs REMS for Fentora, Actiq

The Food and Drug Administration has approved a risk evaluation and mitigation strategy for two painkillers made by Cephalon, the drug maker said Thursday.

July 20, 2011
FDA committee doesn't recommend regulatory approval for dapagliflozin

A Food and Drug Administration committee of experts has advised against approving a drug for Type 2 diabetes made by AstraZeneca and Bristol-Myers Squibb, the companies said Tuesday.

July 20, 2011
Purdue launches RxSafetyMatters.org

Purdue Pharma has launched a new website designed to combat abuse of prescription drugs, the company said Wednesday.

July 20, 2011
Valeant inks distribution agreement for Zuacta in Canada

Canadian drug maker Valeant Pharmaceuticals International has signed an agreement with Sanofi’s subsidiary in Canada to distribute a topical medication for osteoarthritis in the country.

July 19, 2011
Investigational antidepressant garners positive results in late-stage clinical trial

Patients taking an investigative antidepressant undergoing late-stage clinical development showed “significant” improvement, according to study results released Monday.

© 2013 Drug Store News. All Rights Reserved.